1. Preclinical and clinical assessment of immune checkpoint inhibitor-associated left ventricular dysfunction. (25th November 2020) Authors: Michel, L; Hendgen-Cotta, U.B; Mincu, R.I; Helfrich, I; Korste, S; Mrotzek, S.M; Rischpler, C; Herrmann, K; Ugurel, S; Zimmer, L; Coman, C; Ahrends, R; Schadendorf, D; Rassaf, T; Totzeck, M Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Tumor necrosis factor alpha blockade prevents immune checkpoint inhibitor therapy-related cardiotoxicity. (25th November 2020) Authors: Michel, L; Hendgen-Cotta, U.B; Mincu, R.I; Helfrich, I; Korste, S; Mrotzek, S.M; Schadendorf, D; Rassaf, T; Totzeck, M Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗